Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS

Govt Biotech SRF Recruitment at Ministry of AYUSH, Siddha Central Research Institute

Cognizant Data Analyst Life Science Recruitment | Apply Online

VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS
  • BiotechToday
  • World

VISCERAL METASTASIS MECHANISM PROVED ESSENTIAL FOR CRPC PATIENTS

bioxone October 17, 2020October 17, 2020

Aishila Kar,Amity University Kolkata

An important poor prognostic factor of prostate cancer (PC), visceral metastasis (VM), is not commonly observed in castration sensitive progression but continuously seen after castration-resistant progression. Still, the site, timing of appearance, and incidence of VM in castration-resistant patients have not yet been fully explained.

 At Kanazawa University Hospital, demographic, surgical, pathological, and follow-up data of PC patients have been treated between January 2000 and December 2016 were retrospectively examine using their medical charts. From these figures, risk factors of visceral metastasis and survival of patients with it were explained.

21 patients (1.5%) had visceral metastasis at diagnosis out of 1364 patients. 55 experienced the emergence of a new VM during treatment course out of 179 (13.1%) castration-resistant patients. Incidence of new VM, especially non-lung, like liver and adrenal metastases, grow significantly in proportion with the number of authorised treatments. Multivariate analysis showed that T stage, M stage, age, and treatment report with androgen receptor (AR) signalling-targeted agents and/or taxanes significantly grow the risk of VM. Compared with the group with VM at diagnosis, survival after diagnosis of VM following treatment was shorter.

In spite of the fact that sequential use of new AR signalling-targeted agents and taxanes for castration-resistant prostate cancer (CRPC) is a standard treatment plan, it frequently results in the development of VM. Explaining the mechanisms of VM are key to enhance survival in patients with CRPC.

Also read: Ex-situ DNA synthesis accelerated

SOURCE- https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/125241-androgen-receptor-signaling-targeted-therapy-and-taxane-chemotherapy-induce-visceral-metastasis-in-castration-resistant-prostate-cancer.htmldoi: 10.1002/pros.24082.

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged adrenal metastasis androgen receptor cancer castration-resistance CRPC liver patients prostate cancer signalling targeted agents surgical taxanes visceral metastasis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

Cognizant Data Analyst Life Science Recruitment | Apply Online

bioxone October 17, 2020

-Shristi Sharma, Team bioXone Cognizant Data Analyst Life Science Recruitment – Apply Online. Life Sciences Trainee Junior Data Analyst position vacant for eligible candidates at Cognizant. Cognizant is hiring life sciences candidates for a Junior Data Analyst position. Interested and eligible candidates check out all of the details on the same below: Job Title: Junior […]

Related Post

  • BiotechToday
  • World

Poor Oral Hygiene could result in Heart Infection

bioxone April 22, 2021April 22, 2021

Thota Kanishka Rao, Amity University Kolkata Good oral hygiene is far better than having to take antibiotics in dental procedures for some heart patients to prevent a heart infection resulting from bacterial infections around the teeth. Infective endocarditis (IE), additionally called bacterial endocarditis, is a heart infection brought about by microbes that enter the circulation […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Does obesity decrease brain functions?

bioxone October 3, 2020October 3, 2020

Camelia Bhattacharyya, Amity University Kolkata “Is eating healthy food enough to maintain proper body weight?”, “Is obesity genetic?” “why is obesity a problem?”, these are a few questions most of us search on the internet every day, sometimes due to the fear of the diseases which follows obesity while other times due to maintaining physical […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Moderna’s mRNA–1273 granted emergency use authorization by FDA

bioxone December 28, 2020December 28, 2020

Prama Ghosh, Amity University Kolkata The Food and Drug Administration announced granted emergency use authorization to Moderna’s mRNA–1273, it’s COVID-19 vaccine for use in individuals 18 and older Friday night, the second vaccination against the coronavirus in the United States one week after the agency authorized a similar vaccine from Pfizer and BioNTech. Moderna’s vaccine […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy